ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 2 filers reported holding ARRAY BIOPHARMA INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $4,465,000 | -45.0% | 96,380 | -83.1% | 0.44% | -64.1% |
| Q4 2018 | $8,112,000 | -2.2% | 569,298 | +4.3% | 1.22% | +111.2% |
| Q3 2018 | $8,295,000 | -9.3% | 545,711 | +0.2% | 0.58% | -9.2% |
| Q2 2018 | $9,143,000 | +237.4% | 544,891 | +228.1% | 0.64% | +198.1% |
| Q1 2018 | $2,710,000 | – | 166,076 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|